Transition metal complexes have enormous potential as diagnostic and therapeutic agents, but their internalization and distribution in living cells are only poorly understood. Here, we perform one of the few systematic explorations of the uptake efficiency and mechanism of a class of metal complexes: luminescent dipyridophenazine (dppz) complexes of ruthenium(II). Substitution of the ancillary ligands permits variation in the overall complex charge, size, and hydrophobicity. We find that internalization of these complexes occurs mostly through passive diffusion, driven by the membrane potential, and that hydrophobicity, rather than size, is the most important determinant of compound accumulation. Across different cell types with all compoun...
Despite their potential to overcome critical limitations of conventional organic dyes, metal complex...
Knowledge about mechanisms behind interactions of molecules with biomembranes and cellular uptake is...
Ruthenium polypyridyl complexes show great promise as new photodynamic therapy (PDT) agents. However...
Transition metal complexes provide a promising avenue for the design of therapeutic and diagnostic a...
The cellular uptake of a series of dipyridophenazine (dppz) complexes of Ru(II) was examined by flow...
Transition metal complexes offer great potential as diagnostic and therapeutic agents, and a growing...
Here, we examine the photophysical properties of five ruthenium(II) complexes comprising two 4,7-dip...
In an effort to develop octahedral metal complexes as chemotherapeutic and diagnostic agents targete...
The cellular uptake and localization of a Ru−octaarginine conjugate with and without an appended flu...
This is the publisher’s final pdf. The published article is copyrighted by the Royal Society of Chem...
Ruthenium dipyridophenazine (dppz) complexes are virtually non-emissive in aqueous solutions but sho...
International audienceHere, we examine the photophysical properties of five ruthenium(II) complexes ...
Ruthenium-based compounds are developed for anticancer treatment, but their mode of action including...
[[abstract]]A fluorescent polypyridyl ruthenium complex was successfully prepared using an amide bon...
The pathways involved in cellular uptake and accumulation of iminopyridine complexes of general form...
Despite their potential to overcome critical limitations of conventional organic dyes, metal complex...
Knowledge about mechanisms behind interactions of molecules with biomembranes and cellular uptake is...
Ruthenium polypyridyl complexes show great promise as new photodynamic therapy (PDT) agents. However...
Transition metal complexes provide a promising avenue for the design of therapeutic and diagnostic a...
The cellular uptake of a series of dipyridophenazine (dppz) complexes of Ru(II) was examined by flow...
Transition metal complexes offer great potential as diagnostic and therapeutic agents, and a growing...
Here, we examine the photophysical properties of five ruthenium(II) complexes comprising two 4,7-dip...
In an effort to develop octahedral metal complexes as chemotherapeutic and diagnostic agents targete...
The cellular uptake and localization of a Ru−octaarginine conjugate with and without an appended flu...
This is the publisher’s final pdf. The published article is copyrighted by the Royal Society of Chem...
Ruthenium dipyridophenazine (dppz) complexes are virtually non-emissive in aqueous solutions but sho...
International audienceHere, we examine the photophysical properties of five ruthenium(II) complexes ...
Ruthenium-based compounds are developed for anticancer treatment, but their mode of action including...
[[abstract]]A fluorescent polypyridyl ruthenium complex was successfully prepared using an amide bon...
The pathways involved in cellular uptake and accumulation of iminopyridine complexes of general form...
Despite their potential to overcome critical limitations of conventional organic dyes, metal complex...
Knowledge about mechanisms behind interactions of molecules with biomembranes and cellular uptake is...
Ruthenium polypyridyl complexes show great promise as new photodynamic therapy (PDT) agents. However...